CD34 and peripheral arterial disease: Meanwhile, Fadini et al. [141] determined that CD34+ cEPCs were reduced in DR patients (without discriminating between PDR and NPDR) while CD34+KDR+ cEPCs levels were lower in DM patients with PAD, existing differences in the CD34+/CD34+KDR+ ratio between DR and PAD patients.